Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Total Current Liabilities

$961.30M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Total Current Liabilities

Latest reported$961.30Mperiod endingJun 30, 2026

BIO Quarterly Current Liabilities ($23.90M → $961.30M)

Quarterly total current liabilities

High-resolution chart · PNG

BIO total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Total Current Liabilities — Quarterly (USD)
Period ending	Total Current Liabilities (USD)
Jun 30, 2026	961,300,000
Mar 31, 2026	917,000,000
Dec 31, 2025	517,000,000
Sep 30, 2025	522,299,999
Jun 30, 2025	548,900,000
Mar 31, 2025	506,600,000
Dec 31, 2024	467,800,000
Sep 30, 2024	497,943,000
Jun 30, 2024	486,961,000
Mar 31, 2024	466,154,000
Dec 31, 2023	522,799,000
Sep 30, 2023	558,176,000
Jun 30, 2023	581,982,000
Mar 31, 2023	589,623,000
Dec 31, 2022	568,708,000
Sep 30, 2022	570,677,000
Jun 30, 2022	613,714,000
Mar 31, 2022	648,331,000
Dec 31, 2021	680,938,000
Sep 30, 2021	649,916,000
Jun 30, 2021	587,052,000
Mar 31, 2021	609,892,000
Dec 31, 2020	631,536,000
Sep 30, 2020	986,657,000
Jun 30, 2020	926,895,000
Mar 31, 2020	869,254,000
Dec 31, 2019	905,495,000
Sep 30, 2019	434,040,000
Jun 30, 2019	445,977,000
Mar 31, 2019	444,306,000
Dec 31, 2018	450,795,000
Sep 30, 2018	453,159,000
Jun 30, 2018	442,421,000
Mar 31, 2018	456,198,000
Dec 31, 2017	502,696,000
Sep 30, 2017	466,456,000
Jun 30, 2017	455,110,000
Mar 31, 2017	407,504,000
Dec 31, 2016	471,322,000
Sep 30, 2016	442,718,000
Jun 30, 2016	410,405,000
Mar 31, 2016	400,888,000
Dec 31, 2015	441,351,000
Sep 30, 2015	435,235,000
Jun 30, 2015	403,894,000
Mar 31, 2015	416,882,000
Dec 31, 2014	446,761,000
Sep 30, 2014	503,783,000
Jun 30, 2014	480,248,000
Mar 31, 2014	481,251,000
Dec 31, 2013	487,472,000
Sep 30, 2013	462,885,000
Jun 30, 2013	431,244,000
Mar 31, 2013	446,740,000
Dec 31, 2012	472,400,000
Sep 30, 2012	433,666,000
Jun 30, 2012	417,184,000
Mar 31, 2012	444,080,000
Dec 31, 2011	459,115,000
Sep 30, 2011	415,326,000
Jun 30, 2011	442,844,000
Mar 31, 2011	427,591,000
Dec 31, 2010	666,627,000
Sep 30, 2010	410,694,000
Jun 30, 2010	389,495,000
Mar 31, 2010	398,170,000
Dec 31, 2009	419,972,000
Sep 30, 2009	415,695,000
Jun 30, 2009	383,609,000
Mar 31, 2009	355,879,000
Dec 31, 2008	418,034,000
Sep 30, 2008	385,814,000
Jun 30, 2008	408,087,000
Mar 31, 2008	387,446,000
Dec 31, 2007	414,168,000
Sep 30, 2007	286,461,000
Jun 30, 2007	281,849,000
Mar 31, 2007	272,091,000
Dec 31, 2006	319,533,000
Sep 30, 2006	281,312,000
Jun 30, 2006	281,021,000
Mar 31, 2006	259,132,000
Dec 31, 2005	319,243,000
Sep 30, 2005	299,233,000
Jun 30, 2005	290,848,000
Mar 31, 2005	298,480,000
Dec 31, 2004	315,375,000
Sep 30, 2004	272,374,000
Jun 30, 2004	211,137,000
Mar 31, 2004	221,196,000
Dec 31, 2003	239,252,000
Sep 30, 2003	232,326,000
Jun 30, 2003	219,115,000
Mar 31, 2003	217,191,000
Dec 31, 2002	222,009,000
Sep 30, 2002	212,582,000
Jun 30, 2002	202,701,000
Mar 31, 2002	194,454,000
Dec 31, 2001	199,106,000
Sep 30, 2001	214,693,000